Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3), a company commercializing IzoView, a dedicated breast-computed tomography (“CT”) imaging platform for the more accurate detection and diagnosis of breast cancers, has engaged Oak Hill Financial to provide financial marketing services for the company. In addition, Izotropic has retained Tyler Muir of TMM Capital Advisory to provide social media and communications services. A leading Canadian marketing and distribution firm, Oak Hill Financial focuses on IIROC retail brokerage networks with an expertise in servicing both asset managers and public companies. The company’s experienced team is comprised of former asset management wholesalers, research analysts and capital market professionals who specialize in building credibility for their clients within a network of more than 10,000 Canadian IIROC retail brokers and more than 300 North American funds. The initial agreement with Oak Hill Financial is a three-month term with an option for renewal. IZOZF will pay a monthly fee of $10,000 as well as issue 100,000 stock options to Oak Hill Financial; the options are at an exercise price of $0.84 for an 18-month term. IZOZF has contracted with Muir for an initial six months, also with a renewal option. Muir’s monthly fee is $3,500, and the contract also includes the issuance of 100,000 stock options at an exercise price of $0.84 for a two-year term.
To view the full press release, visit
https://ibn.fm/yTSvD
About Izotropic Corporation
Izotropic is the only publicly traded company commercializing a dedicated breast CT imaging platform — IzoView — for the more accurate detection and diagnosis of breast cancers. To expedite patient and provider access to IzoView, Izotropic’s initial clinical study intends to demonstrate superior performance of diagnostic breast CT imaging over diagnostic mammography procedures; the study is planned for initiation in Q2 2022. In follow-on clinical studies, Izotropic intends to validate platform applications including breast screening in radiology, treatment planning and monitoring in surgical oncology, and breast reconstruction and implant monitoring in plastic and reconstructive surgery. IzoView produces high-resolution breast images in true 3D and is ideal for imaging patients with dense breast tissue. A single 10-second scan acquires approximately 500 images without painful breast compression or continual technician breast handling, providing a more comfortable patient experience with low-radiation dose levels. In addition to improved detection capabilities, Izotropic anticipates IzoView’s higher-resolution 3D images could provide more accurate margin analysis (viewing edges of a tumor), lesion characterization (determining the qualities of an abnormality), and higher spatial resolution (the imaging ability to differentiate between internal breast structures). For more information about the company, please visit
www.IzoCorp.com.
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork.